At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Stereotactic Radiosurgeryradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of Stereotactic Liver Irradiation for Hepatocellular Carcinoma
In Brief
A clinical study evaluating Stereotactic Radiosurgery for Adult Hepatocellular Carcinoma and 3 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This pilot clinical trial studies stereotactic body radiation therapy in treating patients with liver cancer that cannot be removed by surgery. Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Localized Non-Resectable Adult Liver Carcinoma, Recurrent Adult Liver Carcinoma
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
First PostedJul 2013
Primary CompletionMay 2016
Study CompletionMay 2019
TodayJul 2026
First PostedJul 15, 2013
Enrollment StartOct 7, 2010
Primary CompletionMay 9, 2016
Study CompletionMay 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 13.0 years ago
Interventions
Stereotactic Radiosurgeryradiation
Undergo SBRT